Crawford Investment Counsel’s Edwards Lifesciences EW Stock Holding History

Crawford Investment Counsel’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7,229	Closed	-$818K	–	283
2021 Q3	$818K	Sell	7,229 -7	-0.1%	-$799	0.02%	203
2021 Q2	$749K	Buy	7,236 +18	+0.2%	+$1.7K	0.02%	207
2021 Q1	$604K	Buy	7,218 +45	+0.6%	+$3.8K	0.01%	205
2020 Q4	$654K	Buy	7,173 +60	+0.8%	+$4.98K	0.02%	196
2020 Q3	$568K	Buy	7,113 +171	+2%	+$13.3K	0.02%	197
2020 Q2	$480K	Hold	6,942	–	–	0.01%	206
2020 Q1	$436K	Sell	6,942 -6	-0.1%	-$433	0.01%	208
2019 Q4	$540K	Buy	6,948 +6	+0.1%	+$469	0.01%	216
2019 Q3	$509K	Buy	+6,942	New	+$488K	0.01%	215
2017 Q3	–	Sell	-6,300	Closed	-$248K	–	244
2017 Q2	$248K	Sell	6,300 -300	-5%	-$10.9K	0.01%	220
2017 Q1	$207K	Buy	+6,600	New	+$207K	0.01%	237
2016 Q4	–	Sell	-6,900	Closed	-$277K	–	253
2016 Q3	$277K	Hold	6,900	–	–	0.01%	219
2016 Q2	$229K	Hold	6,900	–	–	0.01%	235
2016 Q1	$203K	Buy	+6,900	New	+$190K	0.01%	240
2015 Q1	–	Sell	-13,164	Closed	-$279K	–	240
2014 Q4	$279K	Hold	13,164	–	–	0.01%	219
2014 Q3	$224K	Buy	+13,164	New	+$208K	0.01%	228

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Crawford Investment Counsel's EW Position: Q4 2021 in Review

Crawford Investment Counsel sold out of Edwards Lifesciences (EW) in Q4 2021, closing a stake of 7,229 shares — an estimated $818K sold.

Crawford Investment Counsel first reported a position in EW in Q3 2014 and held it in 16 quarters. The position peaked at $818K in Q3 2021. 1,319 funds tracked by Wall St. Rank hold EW as of Q4 2021.

Crawford Investment Counsel reported no remaining Edwards Lifesciences position as of Q4 2021 after selling out during the quarter.
Crawford Investment Counsel sold 7,229 Edwards Lifesciences shares in Q4 2021, an estimated $818K.
Crawford Investment Counsel first reported a position in Edwards Lifesciences in Q3 2014 and held it in 16 quarters.
Crawford Investment Counsel's Edwards Lifesciences position peaked at $818K in Q3 2021.
1,319 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2021.

Based on Crawford Investment Counsel's 13F filing for Q4 2021, filed 7 Feb 2022.